AsabaH., FurstP., OulesR., YahielV., ZimmermanL., and BergstromJ.: The effect of hemodialysis on endogenous middle molecules in uremic patients.Clin. Nephrol.11, 257, 1979.
2.
BabbA.L., PopovichR.P., ChristopherT.G., and ScribnerB.H.: The genesis of the square meter-hour hypothesis.Trans. Amer. Soc. Artif. Int. Organs, 17, 81, 1971.
3.
BabbA.L., FarrellP.C., UvelliD.A., and ScribnerB.H.: Hemodialyzer evaluation by examination of solute molecular spectra.Trans. Amer. Soc. Artif. Int. Organs, 18, 98, 1972.
4.
BergstromJ., and FurstP.: Uremic middle molecules.Clin. Nephrol., 5, 143, 1976.
5.
BergstromJ., FrustP., and ZimmermanL.: Uremic middle molecules exist and are biologically active.Clin. Nephrol., 11, 229, 1979.
6.
ChapmanG.V., MahonyJ.F., and FarrellP.C.: A crossover study of short time dialysis.Clin. Nephrol., 13, 78, 1980.
7.
ChapmanG.V., WardR.A., and FarrellP.C.: Separation and quantification of the «middle molecules» in uremia.Kidney Int., 17, 82, 1980.
8.
CichockiT., HanickiZ., KleinA., KomorowskaZ., Sarnecka-KellerM., and SalowiczW.: Influence of middle-molecular-weight solutes from dialysate on the migration rate of leukocytes.Kidney Int., 17, 231, 1980.
9.
Funck-BrentanoJ.L., CueilleC.F., and ManN.K.: A defense of the middle molecule hypothesis.Kidney Int.13, 531, 1978.
10.
FurstP., ZimmermanL., and BergstromJ.: Determination of endogenous middle molecules in normal and uremic body fluids.Clin. Nephrol., 5, 178, 1976.
11.
GotchF.A., SargentJ.A., and PetersJ.H.: Studies on the molecular etiology of uremia.Kidney Int.7, 5276, 1975.
12.
GotchF.A., SargentJ.A., KeenM., LamM., ProwittM., and GradyM.: Clinical results of intermittent dialysis therapy (IDT) guided by ongoing kinetic analysis of urea metabolism.Trans. Amer. Soc. Artif. Int. Organs, 22, 175, 1976.
13.
HoneP.W.E., WardR.A., MahonyJ.F., and FarrellP.C.: Hemodialyser performance: An assessment of currently available units.J. Dial., 1, 285, 1977.
14.
NavarroJ., TouraineJ.L., CorreC., and TraegerJ.: Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with «middle molecules».Cell Immunol.31, 349, 1977.
15.
RinandoJ.B., GallieP., CrevatA., SaingraS., and MurisasioA.: Action of middle molecules from chronic renal insufficiency on mitochondria respiration.Biomed., 30, 215, 1979.
